HopeStage
Back to overview

Depression studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 589-600 of 7,264
Drug study icon
CompletedNCT03866174

Psilocybin for Major Depressive Disorder (MDD)

Official study title

A Randomized, Double-Blind Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)

This study has finished and is no longer accepting participants.

Multiple locations, including San Francisco
DepressionMedication studyAges 21–65
Countries
United States
Sponsor
Usona Institute
Device study icon
Enrolling By InvitationNCT06919133

The Effect of Digital Markers in the Self-management of Depressive Symptoms

Official study title

The Effect of Digital Markers in the Self-management of Depressive Symptoms - The MENTINA Randomized Controlled Parallel Group Trial

This study is by invitation only.

Multiple locations, including Frederiksberg
DepressionDevice studyAges 18+
Countries
Denmark, Germany, Spain
Sponsor
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Behavioral study icon
Not Yet RecruitingACTRN12612000859886

A controlled study of a modified neurolinguistic programming technique to improve emotional control in people with depression in primary care.

Official study title

For patients with depression in primary care with a PHQ-9 score between 10 and 20 will be given a modified neurolinguistic programming technique and advised to exercise regularly and given sleep hygiene advice versus advised to exercise regularly and given sleep hygiene advice with the outcome at 6 weeks of a PHQ-9 score <7 and the dichotomous outcome of do you feel in control of your emotions yes/no

This study isn't recruiting yet.

In New Zealand
DepressionInterventional studyAges 16–75
Countries
New Zealand
Sponsor
Prof Bruce Arroll
Drug study icon
Not Yet RecruitingACTRN12609000831280

Perinatal treatment of depression

Official study title

Maternal and infant outcomes following antenatal exposure to specific serotonin reuptake inhibitor (SSRI) and serotonin and noradrenaline reuptake inhibitor (SNRI )medications

This study isn't recruiting yet.

Location not clearly listed
DepressionInterventional studyAges 18+
Countries
Sponsor
Royal Brisbane Hospital
Device study icon
RecruitingNCT03417960

Feasibility of accelerated magnetic stimulation for postpartum depression

About this title

Accelerated iTBS for Post Partum Depression

Read the official source — NCT03417960
Official study title

An Open Label Study to Assess the Feasibility and Tolerability of Accelerated Theta Burst Repetitive Transcranial Magnetic Stimulation (iTBS-rTMS) for the Treatment of Post-Partum Depression

In Charleston
DepressionDevice studyAges 18–50
Countries
United States
Sponsor
Medical University of South Carolina

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.